The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale ...
Jan 11, 2022
0
50
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal antibiotic ointment, ...
Oct 10, 2023
0
35
A team of medical researchers affiliated with multiple institutions in the U.S. working with a colleague from Spain has found via clinical trial that adding tirzepatide (brand name Mounjaro) to basal insulin therapies can ...
(HealthDay)—In the 14 days following each of the two doses of BNT162b2 mRNA vaccine, there was no increase in the incidence of acute myocardial infarction, stroke, or pulmonary embolism among individuals aged 75 years or ...
Dec 10, 2021
0
7
The largest ever randomized controlled trial in IgA nephropathy has found that treatment with methylprednisolone—a cheap, widely used corticosteroid drug—halves the risk of losing kidney function and kidney failure, and ...
May 17, 2022
0
11
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends that primary care clinicians take steps to prevent cavities in young children, many of whom may not visit a dentist. The final recommendation statement ...
Dec 7, 2021
0
3
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according ...
Feb 4, 2022
0
101
A clinical trial led by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, has concluded that a Chinese traditional medicine compound, Tongxinluo, reduced major adverse cardiac ...
The U.S. Preventive Services Task Force (USPSTF) concludes that people aged 40 to 75 years at high risk for cardiovascular disease (CVD) should receive statins. This finding forms the basis of a final recommendation statement ...
Aug 24, 2022
0
17
